AKTX Akari Therapeutics Plc: institutional ownership and insider trading
11 funds reported holding $1.66M of Akari Therapeutics Plc in their latest 13F filings; in Q2 2026 funds net bought $1.03M, with 6 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
AKTX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$4.81M, EPS 0.00
- Quarter ended Mar 31, 2026: revenue n/a, net income −$14.5M, EPS 0.00
- Quarter ended Dec 31, 2025: revenue n/a, net income −$5.30M, EPS 0.00
- Quarter ended Sep 30, 2025: revenue n/a, net income −$6.40M, EPS 0.00
Famous investors holding AKTX
- Ken Griffin (Citadel Advisors): $102K, 0.0% of the portfolio
Largest institutional holders of AKTX
- MMCAP International Inc. SPC — $1.02M
- Cresset Asset Management, LLC — $211K
- JANE STREET GROUP, LLC — $158K
- HRT FINANCIAL LP — $140K
- CITADEL ADVISORS LLC — $102K
- GAMMA Investing LLC — $22.4K
- IFP Advisors, Inc — $1.68K
- SBI Securities Co., Ltd. — $140
- Caitong International Asset Management Co., Ltd — $82
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO — $72
Recent AKTX insider trades
- Aug 25, 2025: Gaslightwala Abizer bought 21,000 shares ($19.5K)
- Jun 24, 2025: Gaslightwala Abizer bought 6,146 shares ($7.12K)
- Jun 20, 2025: Gaslightwala Abizer bought 10,000 shares ($12.0K)
- Jun 17, 2025: Gaslightwala Abizer bought 15,000 shares ($18.0K)
5%+ owners
- MMCAP International Inc. SPC: 8.0% (Schedule 13G, filed Jun 8, 2026)
- Bank of Montreal: 5.7% (Schedule 13G, filed Aug 12, 2026)
- White Lion Capital LLC: 5.0% (Schedule 13G, filed Aug 7, 2026)
Who owns the most AKTX stock?
The largest institutional holders of Akari Therapeutics Plc in the latest 13F filings are MMCAP International Inc. SPC ($1.02M), Cresset Asset Management, LLC ($211K), JANE STREET GROUP, LLC ($158K).
Are insiders buying or selling AKTX?
No open-market insider buys or sells of Akari Therapeutics Plc were reported in the last 12 months.
Which famous investors own AKTX?
Ken Griffin.